Recombinant Human START domain containing 7 protein (ab75464)

製品の概要

  • 製品名Recombinant Human START domain containing 7 protein
  • タンパク質長Full length protein

製品の詳細

  • 由来Recombinant
  • 由来Escherichia coli
  • アミノ酸配列
    • 生物種Human

特性

Our Abpromise guarantee covers the use of ab75464 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Western blot

    ELISA

    SDS-PAGE

  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 20% Glycerol, 50mM Tris acetate, 1mM EDTA, pH 7.5

関連情報

  • 別名
    • Gestational trophoblastic tumor protein 1
    • GTT1
    • Hypothetical protein STARD7
    • Protein GTT1
    • StAR related lipid transfer protein 7
    • StAR-related lipid transfer protein 7, mitochondrial
    • StARD7
    • START domain containing protein 7
    • START domain-containing protein 7
    see all
  • 関連性Although the function of this gene is not known, its existence is supported by mRNA and EST data. The predicted gene product contains a region similar to the STAR-related lipid transfer (START) domain, which is often present in proteins involved in the cell signalling mediated by lipid binding. Two alternatively spliced transcript variants that encode an identical protein have been reported.
  • 細胞内局在Mitochondrial

Recombinant Human START domain containing 7 protein 画像

  • SDS-PAGE showing ab75464 at approximately 34kDa.

Recombinant Human START domain containing 7 protein (ab75464) 使用論文

ab75464 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab75464.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"